Island Pharmaceuticals Limited (ILA.AX)
AUD 0.17
(0.0%)
AUD 0.17
(0.0%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 | 421.96 Thousand AUD | 0.0% |
| 2023 | - AUD | 0.0% |
| 2022 | - AUD | 0.0% |
| 2021 | - AUD | 0.0% |
| 2020 | - AUD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q3 | 421.96 Thousand AUD | -16.91% |
| 2024 Q2 | 507.83 Thousand AUD | 0.0% |
| 2024 Q1 | 507.83 Thousand AUD | 0.0% |
| 2024 Q4 | 421.96 Thousand AUD | 0.0% |
| 2024 FY | 421.96 Thousand AUD | 0.0% |
| 2023 Q2 | 108.11 Thousand AUD | 0.0% |
| 2023 Q1 | 108.11 Thousand AUD | 0.0% |
| 2023 Q3 | - AUD | -100.0% |
| 2023 Q4 | - AUD | 0.0% |
| 2023 FY | - AUD | 0.0% |
| 2022 Q2 | - AUD | 0.0% |
| 2022 Q1 | - AUD | 0.0% |
| 2022 FY | - AUD | 0.0% |
| 2022 Q4 | - AUD | 0.0% |
| 2022 Q3 | - AUD | 0.0% |
| 2021 Q1 | - AUD | 0.0% |
| 2021 FY | - AUD | 0.0% |
| 2021 Q4 | - AUD | 0.0% |
| 2021 Q3 | - AUD | 0.0% |
| 2020 FY | - AUD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| AdAlta Limited | 2.49 Million AUD | 83.084% |
| Acrux Limited | 1.48 Million AUD | 71.623% |
| Actinogen Medical Limited | 319.06 Thousand AUD | -32.25% |
| AnteoTech Limited | 23.59 Thousand AUD | -1688.606% |
| Argenica Therapeutics Limited | - AUD | -Infinity% |
| Arovella Therapeutics Limited | - AUD | -Infinity% |
| Anatara Lifesciences Ltd | - AUD | -Infinity% |
| Alterity Therapeutics Limited | 159.04 Thousand AUD | -165.314% |
| Amplia Therapeutics Limited | 1.56 Million AUD | 72.981% |
| Avecho Biotechnology Limited | 175.15 Thousand AUD | -140.917% |
| Bio-Gene Technology Limited | - AUD | -Infinity% |
| Biome Australia Limited | 1.3 Million AUD | 67.683% |
| Biotron Limited | 7130.00 AUD | -5818.205% |
| Botanix Pharmaceuticals Limited | - AUD | -Infinity% |
| BTC Health Limited | - AUD | -Infinity% |
| Chimeric Therapeutics Limited | - AUD | -Infinity% |
| CSL Limited | 18.24 Billion AUD | 99.998% |
| Clarity Pharmaceuticals Ltd | - AUD | -Infinity% |
| Clinuvel Pharmaceuticals Limited | 879.78 Thousand AUD | 52.037% |
| Cynata Therapeutics Limited | - AUD | -Infinity% |
| Dimerix Limited | 149.68 Thousand AUD | -181.908% |
| EZZ Life Science Holdings Limited | 123.85 Thousand AUD | -240.692% |
| Hexima Limited | - AUD | -Infinity% |
| Immuron Limited | 173.49 Thousand AUD | -143.213% |
| Immutep Limited | 1.22 Million AUD | 65.645% |
| Imugene Limited | 1.54 Million AUD | 72.722% |
| Invex Therapeutics Ltd | - AUD | -Infinity% |
| Memphasys Limited | 4.41 Million AUD | 90.438% |
| Nanollose Limited | 42.53 Thousand AUD | -892.166% |
| Neuren Pharmaceuticals Limited | - AUD | -Infinity% |
| Noxopharm Limited | - AUD | -Infinity% |
| NeuroScientific Biopharmaceuticals Limited | - AUD | -Infinity% |
| Nyrada Inc. | - AUD | -Infinity% |
| Orthocell Limited | 689.69 Thousand AUD | 38.818% |
| PharmAust Limited | - AUD | -Infinity% |
| Patrys Limited | - AUD | -Infinity% |
| Paradigm Biopharmaceuticals Limited | 239.33 Thousand AUD | -76.312% |
| Proteomics International Laboratories Limited | 316.39 Thousand AUD | -33.367% |
| Prescient Therapeutics Limited | 330.48 Thousand AUD | -27.681% |
| PYC Therapeutics Limited | 1.11 Million AUD | 62.08% |
| Race Oncology Limited | - AUD | -Infinity% |
| Radiopharm Theranostics Limited | - AUD | -Infinity% |
| Recce Pharmaceuticals Ltd | 811.19 Thousand AUD | 47.982% |
| Starpharma Holdings Limited | 3.52 Million AUD | 88.039% |
| Telix Pharmaceuticals Limited | 17.44 Million AUD | 97.581% |
| Tissue Repair Ltd | - AUD | -Infinity% |
| Zelira Therapeutics Limited | 5.65 Million AUD | 92.536% |